Lopecillo, Henia C.
HRN: 21-65-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2022
CEFUROXIME 1.5GM (VIAL)
07/28/2022
08/04/2022
IV
1.5
Q8hours
Cholecystitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes